Search Results - "Tekade, Muktika"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    The use of nanoscaffolds and dendrimers in tissue engineering by Gorain, Bapi, Tekade, Muktika, Kesharwani, Prashant, Iyer, Arun K., Kalia, Kiran, Tekade, Rakesh Kumar

    Published in Drug discovery today (01-04-2017)
    “…•Tissue engineering may propose new hope for patients with injuries, or end-stage organ failure.•Dendrimers have gained its importance in tissue…”
    Get full text
    Journal Article
  2. 2

    Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases by Sharma, Piyoosh A, Maheshwari, Rahul, Tekade, Muktika, Tekade, Rakesh Kumar

    Published in Current pharmaceutical design (01-01-2015)
    “…The increasing prevalence and complexity of cardiovascular diseases demand innovative strategies for diagnostic and therapeutic applications to improve patient…”
    Get more information
    Journal Article
  3. 3

    Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics by Tekade, Rakesh K., Tekade, Muktika, Kumar, Manoj, Chauhan, Abhay S.

    Published in Pharmaceutical research (01-03-2015)
    “…ABSTRACT Purpose To formulate dendrimer-stabilized smart-nanoparticle (DSSN; pD-ANP- f ) for the targeted delivery of the highly hydrophobic anticancer drug,…”
    Get full text
    Journal Article
  4. 4

    Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders by Maheshwari, Rahul, Tekade, Muktika, Sharma, Piyoosh A, Tekade, Rakesh Kumar

    Published in Current pharmaceutical design (01-09-2015)
    “…Cardiovascular diseases (CVDs), primarily myocardial infarction (MI), atherosclerosis, hypertension and congestive heart failure symbolize the foremost cause…”
    Get more information
    Journal Article
  5. 5

    Recent Advances in Polymer-Based Nanomaterials for Non-Invasive Photothermal Therapy of Arthritis by Tekade, Muktika, Pingale, Prashant, Gupta, Rachna, Pawar, Bhakti, Tekade, Rakesh Kumar, Sharma, Mukesh Chandra

    Published in Pharmaceutics (22-02-2023)
    “…To date, nanomaterials have been widely used for the treatment and diagnosis of rheumatoid arthritis. Amongst various nanomaterials, polymer-based…”
    Get full text
    Journal Article
  6. 6

    Development of Metronidazole Loaded Chitosan Nanoparticles Using QbD Approach—A Novel and Potential Antibacterial Formulation by Sreeharsha, Nagaraja, Rajpoot, Kuldeep, Tekade, Muktika, Kalyane, Dnyaneshwar, Nair, Anroop B., Venugopala, Katharigatta N., Tekade, Rakesh K.

    Published in Pharmaceutics (25-09-2020)
    “…The aim of this study was to design, optimize, and develop metronidazole (Met) loaded nanoparticles (MetNp) by employing quality-based design (QbD) as well as…”
    Get full text
    Journal Article
  7. 7

    siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector by Tekade, Rakesh Kumar, Maheshwari, Rahul G S, Sharma, Piyoosh A, Tekade, Muktika, Chauhan, Abhay Singh

    Published in Current pharmaceutical design (01-01-2015)
    “…siRNA technology presents a helpful means of gene silencing in mammalian cells. Advancement in the field includes enhanced attentiveness in the…”
    Get more information
    Journal Article
  8. 8

    Force degradation behavior of glucocorticoid deflazacort by UPLC:isolation,identification and characterization of degradant by FTIR,NMR and mass analysis by Deshmukh, Rajesh, Sharma, Lata, Tekade, Muktika, Kesharwani, Prashant, Trivedi, Piyush, Tekade, Rakesh K

    Published in Journal of biomedical research (01-01-2016)
    “…In this investigation,sensitive and reproducible methods are described for quantitative determination of deflazacort in the presence of its degradation…”
    Get full text
    Journal Article
  9. 9
  10. 10

    RNAi-combined nano-chemotherapeutics to tackle resistant tumors by Tekade, Rakesh Kumar, Tekade, Muktika, Kesharwani, Prashant, D’Emanuele, Antony

    Published in Drug discovery today (01-11-2016)
    “…•Nanotechnology can protect siRNA against RNAse degradation.•siRNA adopts an alternative pathway to knock genes with high specificity to cure cancer.•An ideal…”
    Get full text
    Journal Article
  11. 11

    Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers by Maheshwari, Rahul, Tekade, Muktika, Gondaliya, Piyush, Kalia, Kiran, D'Emanuele, Antony, Tekade, Rakesh Kumar

    Published in Nanomedicine (01-11-2017)
    “…RNA interference (RNAi) therapeutics (siRNA, miRNA, etc.) represent an emerging medicinal remedy for a variety of ailments. However, their low serum stability…”
    Get full text
    Journal Article Book Review
  12. 12

    RNAi-combined nano-chemotherapeutics to tackle resistant tumors: Keynote by Tekade, Rakesh Kumar, Tekade, Muktika, Kesharwani, Prashant, D'Emanuele, Antony

    Published in Drug discovery today (01-11-2016)
    “…The merger of nanotechnology and combination chemotherapy has shown notable promise in the therapy of resistant tumors. The latest scientific attention…”
    Get full text
    Journal Article
  13. 13

    Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy by SreeHarsha, Nagaraja, Maheshwari, Rahul, Al-Dhubiab, Bandar E, Tekade, Muktika, Sharma, Mukesh Chandra, Venugopala, Katharigatta N, Tekade, Rakesh Kumar, Alzahrani, Abdullah M

    Published in International journal of nanomedicine (01-09-2019)
    “…Prostate cancer (PC) has the highest prevalence in men and accounts for a high rate of neoplasia-related death. Doxorubicin (DOX) is one of the most widely…”
    Get full text
    Journal Article
  14. 14

    Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug ‘Etoposide’ by Choudhury, Hira, Maheshwari, Rahul, Pandey, Manisha, Tekade, Muktika, Gorain, Bapi, Tekade, Rakesh Kumar

    Published in Materials Science & Engineering C (01-01-2020)
    “…Etoposide (ETS), topoisomerase-II inhibitor, is a first-line anticancer therapeutics used in diverse cancer types. However, the therapeutic potential of this…”
    Get full text
    Journal Article
  15. 15

    Microsponge Embedded Tablets for Sustained Delivery of Nifedipine by Maheshwari, Rahul, Sharma, Piyoosh, Tekade, Muktika, Atneriya, Umesh, Dua, Kamal, Hansbro, Philp M, Tekade, Rakesh K

    Published in Pharmaceutical nanotechnology (2017)
    “…Nifedipine is a potential therapeutic agent for the treatment of cardiovascular disturbances, although it suffers from short half-life (t1/2, 2 hr). To address…”
    Get more information
    Journal Article
  16. 16

    Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems by Dua, Kamal, Bebawy, Mary, Awasthi, Rajendra, Tekade, Rakesh K, Tekade, Muktika, Gupta, Gaurav, De Jesus Andreoli Pinto, Terezinha, Hansbro, Philip M

    Published in Pharmaceutical nanotechnology (2017)
    “…The respiratory tract as a non-invasive route of drug administration is gaining increasing attention in the present time on achieving both local and the…”
    Get more information
    Journal Article